Baker Brothers Life Sciences Capital (GP), LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Brothers Life Sciences Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Brothers Life Sciences Capital (GP), LLC. Baker Brothers Life Sciences Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Latest Insider Trading Transactions of Baker Brothers Life Sciences Capital (GP), LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, HRTX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO, VPHM
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 26 2011 | HRTX | HERON THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | P | 1,000.00 | 588,600 | 588,600,000 | 588,600 | |
| Apr 26 2011 | HRTX | HERON THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | P | 0.04 | 294,300 | 11,772 | 294,300 | |
| Feb 04 2011 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 15.50 | 1,751,803 | 27,152,947 | 13,470,692 | 11.7 M to 13.5 M (+14.95 %) |
| Mar 11 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.56 | 20,000 | 511,150 | 5,674,104 | 5.7 M to 5.7 M (+0.35 %) |
| Mar 11 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.22 | 49,056 | 1,286,165 | 5,654,104 | 5.6 M to 5.7 M (+0.88 %) |
| Mar 11 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.17 | 1,800 | 47,097 | 5,605,048 | 5.6 M to 5.6 M (+0.03 %) |
| Mar 08 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.13 | 1,826 | 45,887 | 5,603,248 | 5.6 M to 5.6 M (+0.03 %) |
| Mar 08 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 24.90 | 243,285 | 6,057,797 | 5,601,422 | 5.4 M to 5.6 M (+4.54 %) |
| Mar 08 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.39 | 34,592 | 878,343 | 5,358,137 | 5.3 M to 5.4 M (+0.65 %) |
| Mar 08 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.40 | 19,463 | 494,446 | 5,323,545 | 5.3 M to 5.3 M (+0.37 %) |
| Mar 08 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.44 | 41,041 | 1,044,227 | 5,304,082 | 5.3 M to 5.3 M (+0.78 %) |
| Mar 08 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.50 | 9,359 | 238,618 | 5,263,041 | 5.3 M to 5.3 M (+0.18 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.16 | 46,367 | 1,212,826 | 5,253,682 | 5.2 M to 5.3 M (+0.89 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.00 | 28,602 | 743,546 | 5,207,315 | 5.2 M to 5.2 M (+0.55 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.56 | 18,986 | 485,237 | 5,178,713 | 5.2 M to 5.2 M (+0.37 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.57 | 23,545 | 601,944 | 5,159,727 | 5.1 M to 5.2 M (+0.46 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.54 | 681 | 17,393 | 5,136,182 | 5.1 M to 5.1 M (+0.01 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.14 | 23,495 | 590,685 | 5,135,501 | 5.1 M to 5.1 M (+0.46 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.04 | 18,661 | 467,333 | 5,112,006 | 5.1 M to 5.1 M (+0.37 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 24.23 | 13,986 | 338,914 | 5,093,345 | 5.1 M to 5.1 M (+0.28 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 23.89 | 12,897 | 308,051 | 5,079,359 | 5.1 M to 5.1 M (+0.25 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 23.95 | 8,195 | 196,230 | 5,066,462 | 5.1 M to 5.1 M (+0.16 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 23.47 | 24,318 | 570,787 | 5,058,267 | 5 M to 5.1 M (+0.48 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 23.43 | 48,224 | 1,129,811 | 5,033,949 | 5 M to 5 M (+0.97 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 22.87 | 2,393 | 54,726 | 4,985,725 | 5 M to 5 M (+0.05 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 22.88 | 15,333 | 350,821 | 4,983,332 | 5 M to 5 M (+0.31 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 22.88 | 33,009 | 755,163 | 4,967,999 | 4.9 M to 5 M (+0.67 %) |
| Jan 24 2011 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.00 | 355,585 | 9,245,210 | 4,036,097 | 3.7 M to 4 M (+9.66 %) |
| Mar 31 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 21.94 | 82,000 | 1,798,670 | 6,105,365 | 6 M to 6.1 M (+1.36 %) |
| Mar 31 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.00 | 250,000 | 5,499,400 | 6,023,365 | 5.8 M to 6 M (+4.33 %) |
| Oct 29 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 1.18 | 31,666 | 37,461 | 6,666,436 | 6.7 M to 6.7 M (-0.47 %) |
| Oct 29 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 1.19 | 74,670 | 88,738 | 6,698,102 | 6.8 M to 6.7 M (-1.10 %) |
| Oct 29 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 1.30 | 47,978 | 62,371 | 6,772,772 | 6.8 M to 6.8 M (-0.70 %) |
| Oct 29 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 1.28 | 19,671 | 25,120 | 6,820,750 | 6.8 M to 6.8 M (-0.29 %) |
| Sep 30 2010 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 2.45 | 13,137 | 32,188 | 1,242,773 | 1.2 M to 1.2 M (+1.07 %) |
| Sep 30 2010 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 2.45 | 779 | 1,912 | 1,229,636 | 1.2 M to 1.2 M (+0.06 %) |
| Sep 23 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.86 | 179,644 | 2,669,654 | 7,511,046 | 7.7 M to 7.5 M (-2.34 %) |
| Sep 23 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.71 | 227,071 | 3,340,623 | 7,690,690 | 7.9 M to 7.7 M (-2.87 %) |
| Sep 23 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.94 | 610,072 | 9,116,306 | 7,917,761 | 8.5 M to 7.9 M (-7.15 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.00 | 58,262 | 815,551 | 8,527,833 | 8.6 M to 8.5 M (-0.68 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.00 | 29,988 | 419,829 | 8,586,095 | 8.6 M to 8.6 M (-0.35 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.08 | 190,020 | 2,675,729 | 8,616,083 | 8.8 M to 8.6 M (-2.16 %) |
| Aug 11 2010 | INCY | INCYTE CORP | Baker Brothers Life Sciences C ... | Director | Sell | S | 14.09 | 123,602 | 1,741,218 | 8,806,103 | 8.9 M to 8.8 M (-1.38 %) |
| Sep 02 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.54 | 3,969 | 57,699 | 4,929,729 | 4.9 M to 4.9 M (+0.08 %) |
| Sep 02 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.45 | 21,673 | 313,108 | 4,925,760 | 4.9 M to 4.9 M (+0.44 %) |
| Sep 02 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.43 | 12,905 | 186,223 | 4,904,087 | 4.9 M to 4.9 M (+0.26 %) |
| Sep 02 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.37 | 1,842 | 26,474 | 4,891,182 | 4.9 M to 4.9 M (+0.04 %) |
| Sep 02 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.48 | 25,077 | 363,110 | 4,889,340 | 4.9 M to 4.9 M (+0.52 %) |
| Sep 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.78 | 1,460 | 21,585 | 4,934,990 | 4.9 M to 4.9 M (+0.03 %) |
| Sep 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.82 | 3,801 | 56,337 | 4,933,530 | 4.9 M to 4.9 M (+0.08 %) |
| Aug 30 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.44 | 11,038 | 159,336 | 4,864,263 | 4.9 M to 4.9 M (+0.23 %) |
| Aug 30 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.45 | 35,009 | 505,887 | 4,853,225 | 4.8 M to 4.9 M (+0.73 %) |
| Aug 30 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.17 | 890 | 12,607 | 4,818,216 | 4.8 M to 4.8 M (+0.02 %) |
| Aug 30 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.42 | 36,671 | 528,895 | 4,817,326 | 4.8 M to 4.8 M (+0.77 %) |
| Aug 30 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.24 | 24,328 | 346,489 | 4,780,655 | 4.8 M to 4.8 M (+0.51 %) |
| Aug 30 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.24 | 15,775 | 224,672 | 4,756,327 | 4.7 M to 4.8 M (+0.33 %) |
| Aug 23 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.46 | 24,398 | 352,834 | 4,740,552 | 4.7 M to 4.7 M (+0.52 %) |
| Aug 23 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.43 | 43,494 | 627,675 | 4,716,154 | 4.7 M to 4.7 M (+0.93 %) |
| Aug 23 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.51 | 19,973 | 289,850 | 4,672,660 | 4.7 M to 4.7 M (+0.43 %) |
| Aug 23 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.53 | 7,299 | 106,025 | 4,652,687 | 4.6 M to 4.7 M (+0.16 %) |
| Aug 23 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.56 | 12,300 | 179,137 | 4,645,388 | 4.6 M to 4.6 M (+0.27 %) |
| Aug 23 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.65 | 43,005 | 629,856 | 4,633,088 | 4.6 M to 4.6 M (+0.94 %) |
| Aug 18 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 15.00 | 1,845 | 27,675 | 4,590,083 | 4.6 M to 4.6 M (+0.04 %) |
| Aug 18 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.93 | 3,621 | 54,062 | 4,588,238 | 4.6 M to 4.6 M (+0.08 %) |
| Aug 18 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 15.00 | 13,721 | 205,815 | 4,584,617 | 4.6 M to 4.6 M (+0.30 %) |
| Aug 13 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.81 | 8,914 | 131,990 | 4,570,896 | 4.6 M to 4.6 M (+0.20 %) |
| Aug 13 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.85 | 38,494 | 571,540 | 4,561,982 | 4.5 M to 4.6 M (+0.85 %) |
| Aug 13 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.94 | 8,577 | 128,131 | 4,523,488 | 4.5 M to 4.5 M (+0.19 %) |
| Aug 13 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 15.00 | 9,425 | 141,352 | 4,514,911 | 4.5 M to 4.5 M (+0.21 %) |
| Aug 13 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 15.01 | 12,294 | 184,556 | 4,505,486 | 4.5 M to 4.5 M (+0.27 %) |
| Aug 13 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.71 | 9,313 | 136,949 | 4,493,192 | 4.5 M to 4.5 M (+0.21 %) |
| Aug 13 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.74 | 18,893 | 278,517 | 4,483,879 | 4.5 M to 4.5 M (+0.42 %) |
| Aug 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.66 | 19,463 | 285,423 | 4,464,986 | 4.4 M to 4.5 M (+0.44 %) |
| Aug 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.79 | 37,242 | 550,794 | 4,445,523 | 4.4 M to 4.4 M (+0.84 %) |
| Aug 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.82 | 16,350 | 242,302 | 4,408,281 | 4.4 M to 4.4 M (+0.37 %) |
| Aug 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.80 | 46,260 | 684,842 | 4,391,931 | 4.3 M to 4.4 M (+1.06 %) |
| Aug 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.16 | 34,371 | 486,542 | 4,345,671 | 4.3 M to 4.3 M (+0.80 %) |
| Aug 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 14.18 | 10,556 | 149,708 | 4,311,300 | 4.3 M to 4.3 M (+0.25 %) |
| Aug 30 2010 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 25.77 | 8,505 | 219,188 | 4,784,876 | 4.8 M to 4.8 M (+0.18 %) |
| Aug 30 2010 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 25.84 | 26,394 | 681,952 | 4,776,371 | 4.7 M to 4.8 M (+0.56 %) |
| Aug 30 2010 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 25.34 | 30,822 | 781,026 | 4,749,977 | 4.7 M to 4.7 M (+0.65 %) |
| Aug 30 2010 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 25.37 | 44,826 | 1,137,388 | 4,719,155 | 4.7 M to 4.7 M (+0.96 %) |
| Apr 30 2010 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 12.78 | 145,971 | 1,864,940 | 9,080,664 | 8.9 M to 9.1 M (+1.63 %) |
| Apr 30 2010 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 12.76 | 285,183 | 3,638,850 | 8,934,693 | 8.6 M to 8.9 M (+3.30 %) |
| Apr 30 2010 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 12.98 | 243,852 | 3,165,345 | 8,649,510 | 8.4 M to 8.6 M (+2.90 %) |
| Apr 30 2010 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 13.03 | 670,652 | 8,739,199 | 8,405,658 | 7.7 M to 8.4 M (+8.67 %) |
| Apr 30 2010 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 12.73 | 232,656 | 2,962,316 | 7,735,006 | 7.5 M to 7.7 M (+3.10 %) |
| Apr 30 2010 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 12.70 | 348,500 | 4,426,821 | 7,502,350 | 7.2 M to 7.5 M (+4.87 %) |
| Apr 30 2010 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 12.79 | 19,463 | 249,014 | 7,153,850 | 7.1 M to 7.2 M (+0.27 %) |
| Jun 09 2010 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 11.92 | 63,254 | 754,038 | 11,718,889 | 11.7 M to 11.7 M (+0.54 %) |
| Jun 09 2010 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 11.95 | 423,315 | 5,060,519 | 11,655,635 | 11.2 M to 11.7 M (+3.77 %) |
| Jun 09 2010 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 11.87 | 58,977 | 699,945 | 11,232,320 | 11.2 M to 11.2 M (+0.53 %) |
| Jun 09 2010 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 11.90 | 53,523 | 636,993 | 11,173,343 | 11.1 M to 11.2 M (+0.48 %) |
| May 27 2010 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 11.95 | 5,416 | 64,722 | 11,119,820 | 11.1 M to 11.1 M (+0.05 %) |
| May 05 2010 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 12.72 | 203,148 | 2,583,413 | 11,114,404 | 10.9 M to 11.1 M (+1.86 %) |
| May 05 2010 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 12.73 | 48,657 | 619,472 | 10,911,256 | 10.9 M to 10.9 M (+0.45 %) |
| May 05 2010 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 12.68 | 96,934 | 1,228,755 | 10,862,599 | 10.8 M to 10.9 M (+0.90 %) |
| May 05 2010 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 12.74 | 9,731 | 123,993 | 10,765,665 | 10.8 M to 10.8 M (+0.09 %) |
| May 05 2010 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 12.94 | 93,516 | 1,210,265 | 10,755,934 | 10.7 M to 10.8 M (+0.88 %) |
| May 05 2010 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 12.92 | 109,723 | 1,417,446 | 10,662,418 | 10.6 M to 10.7 M (+1.04 %) |
| May 04 2010 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 12.68 | 57,065 | 723,653 | 10,552,695 | 10.5 M to 10.6 M (+0.54 %) |
| May 04 2010 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 12.64 | 241,756 | 3,056,183 | 10,495,630 | 10.3 M to 10.5 M (+2.36 %) |
| May 04 2010 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 12.56 | 7,201 | 90,447 | 10,253,874 | 10.2 M to 10.3 M (+0.07 %) |
| May 04 2010 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 10.75 | 1,562,664 | 16,798,638 | 10,246,673 | 8.7 M to 10.2 M (+17.99 %) |
| Apr 08 2010 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 20.00 | 486,569 | 9,731,380 | 3,680,512 | 3.2 M to 3.7 M (+15.23 %) |
| Jun 02 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 1.58 | 2,238 | 3,536 | 6,840,421 | 6.8 M to 6.8 M (+0.03 %) |
| Jun 02 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 1.64 | 405,401 | 664,736 | 6,838,183 | 6.4 M to 6.8 M (+6.30 %) |
| Jun 02 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 1.56 | 21,604 | 33,750 | 6,432,782 | 6.4 M to 6.4 M (+0.34 %) |
| Jun 02 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 1.60 | 517,045 | 828,409 | 6,411,178 | 5.9 M to 6.4 M (+8.77 %) |
| May 27 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 1.60 | 44,862 | 71,640 | 5,894,133 | 5.8 M to 5.9 M (+0.77 %) |
| May 27 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 1.59 | 64,420 | 102,196 | 5,849,271 | 5.8 M to 5.8 M (+1.11 %) |
| May 27 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 1.60 | 68,534 | 109,558 | 5,784,851 | 5.7 M to 5.8 M (+1.20 %) |
| May 03 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 1.99 | 35,130 | 69,824 | 5,716,317 | 5.7 M to 5.7 M (+0.62 %) |
| May 03 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 1.94 | 4,508 | 8,740 | 5,681,187 | 5.7 M to 5.7 M (+0.08 %) |
| Apr 28 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 1.92 | 112,106 | 215,165 | 5,676,679 | 5.6 M to 5.7 M (+2.01 %) |
| Apr 28 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 1.82 | 34,838 | 63,482 | 5,564,573 | 5.5 M to 5.6 M (+0.63 %) |
| Apr 28 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 2.06 | 3,550 | 7,313 | 5,529,735 | 5.5 M to 5.5 M (+0.06 %) |
| Apr 28 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 2.08 | 7,858 | 16,342 | 5,526,185 | 5.5 M to 5.5 M (+0.14 %) |
| Apr 28 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 2.08 | 22,055 | 45,894 | 5,518,327 | 5.5 M to 5.5 M (+0.40 %) |
| Apr 28 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 2.08 | 17,709 | 36,790 | 5,496,272 | 5.5 M to 5.5 M (+0.32 %) |
| Apr 28 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 2.05 | 44,258 | 90,862 | 5,478,563 | 5.4 M to 5.5 M (+0.81 %) |
| Apr 28 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 2.06 | 389 | 801 | 5,434,305 | 5.4 M to 5.4 M (+0.01 %) |
| Apr 28 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 2.07 | 50,451 | 104,489 | 5,433,916 | 5.4 M to 5.4 M (+0.94 %) |
| Apr 28 2010 | ADLR | ADOLOR CORP | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 2.06 | 5,755 | 11,855 | 5,383,465 | 5.4 M to 5.4 M (+0.11 %) |
| Feb 22 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 17.03 | 68,120 | 1,160,104 | 4,300,744 | 4.2 M to 4.3 M (+1.61 %) |
| Feb 22 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 17.05 | 8,870 | 151,192 | 4,232,624 | 4.2 M to 4.2 M (+0.21 %) |
| Feb 22 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 17.06 | 55,080 | 939,907 | 4,223,754 | 4.2 M to 4.2 M (+1.32 %) |
| Feb 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.98 | 971 | 16,485 | 4,168,674 | 4.2 M to 4.2 M (+0.02 %) |
| Feb 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.93 | 7,100 | 120,199 | 4,167,703 | 4.2 M to 4.2 M (+0.17 %) |
| Feb 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 17.04 | 223,822 | 3,814,240 | 4,160,603 | 3.9 M to 4.2 M (+5.69 %) |
| Feb 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 17.15 | 21,979 | 376,988 | 3,936,781 | 3.9 M to 3.9 M (+0.56 %) |
| Feb 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.93 | 1,070 | 18,118 | 3,914,802 | 3.9 M to 3.9 M (+0.03 %) |
| Feb 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 17.03 | 13,943 | 237,395 | 3,913,732 | 3.9 M to 3.9 M (+0.36 %) |
| Feb 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.87 | 21,703 | 366,219 | 3,899,789 | 3.9 M to 3.9 M (+0.56 %) |
| Feb 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.93 | 7,975 | 135,026 | 3,878,086 | 3.9 M to 3.9 M (+0.21 %) |
| Feb 10 2010 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 16.85 | 43,291 | 729,544 | 3,870,111 | 3.8 M to 3.9 M (+1.13 %) |
| Mar 11 2010 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 34.10 | 15,367 | 524,050 | 4,674,329 | 4.7 M to 4.7 M (+0.33 %) |
| Mar 11 2010 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 33.19 | 43,597 | 1,446,862 | 4,658,962 | 4.6 M to 4.7 M (+0.94 %) |
| Mar 11 2010 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 31.59 | 11,580 | 365,848 | 4,615,365 | 4.6 M to 4.6 M (+0.25 %) |
| Mar 11 2010 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 31.70 | 59,751 | 1,893,874 | 4,603,785 | 4.5 M to 4.6 M (+1.31 %) |
| Aug 17 2009 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 19.60 | 1,962 | 38,455 | 3,826,820 | 3.8 M to 3.8 M (+0.05 %) |
| Aug 17 2009 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 19.99 | 64,668 | 1,292,687 | 3,824,858 | 3.8 M to 3.8 M (+1.72 %) |
| Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 19.70 | 26,808 | 528,034 | 3,760,190 | 3.7 M to 3.8 M (+0.72 %) |
| Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 19.36 | 10,624 | 205,665 | 3,733,382 | 3.7 M to 3.7 M (+0.29 %) |
| Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 19.47 | 249 | 4,848 | 3,722,758 | 3.7 M to 3.7 M (+0.01 %) |
| Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 19.37 | 32,139 | 622,394 | 3,722,509 | 3.7 M to 3.7 M (+0.87 %) |
| Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 19.48 | 8,312 | 161,912 | 3,690,370 | 3.7 M to 3.7 M (+0.23 %) |
| Aug 12 2009 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 19.50 | 12,622 | 246,124 | 3,682,058 | 3.7 M to 3.7 M (+0.34 %) |
| May 26 2009 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 6.10 | 2,910 | 17,744 | 7,134,387 | 7.1 M to 7.1 M (+0.04 %) |
| May 26 2009 | VPHM | VIROPHARMA INC | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 6.08 | 17,459 | 106,228 | 7,131,477 | 7.1 M to 7.1 M (+0.25 %) |